We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Micro-Imaging Technique Reveals Brain's Neuronal Networks

By Biotechdaily staff writers
Posted on 29 May 2007
Scientists have created a new imaging method called ultramicroscopy by combining two older techniques in order for researchers to view the entire brain at a microscopic level. More...


There is currently no technique available that images the entire neuronal network in an intact brain. Although computed tomography (CT) and magnetic resonance imaging (MRI) are utilized for this purpose, they do not have a cellular level resolution to reveal the micro details. Brain sectioning for microscopic imaging is a better alternative, obtaining three-dimensional (3D) images for all the multiple slices, but it is a laborious task and is highly prone for distortions.

Dr. Hans-Ulrich Dodt and colleagues, formerly at the Max Planck Institute of Psychiatry (Munich, Germany) and now at the Vienna University of Technology (Austria), reportedm that their goal was to have a method that will ultimately image all nerve cells with all their connections in the whole mouse brain. The method was published in the April 2007 issue of the journal Nature Methods.

The principle behind the method is that the brain is made translucent by putting in special oil medium, similar to a drop of oil on a paper, which makes it translucent. The organ is then illuminated only in one plane from the side with a laser. The next step involves gathering all the optical sections by a computer and finally obtaining a three-dimensional (3D) reconstruction. The technique's unique benefit is that it can be used to image large macroscopic specimens with microscopic resolution, which was not possible before.

According to Dr. Dodt, ultramicroscopy has even a wider range of applications than confocal microscopy, and therefore, the impact will be enormous. One possible application of the technique is investigation of Alzheimer's disease (AD) brains of mice. Up to now, the industry used a very labor-intensive standard--the histology to test a new Alzheimer drug on AD-modified mice. With ultramicroscopy, it should be possible to accomplish the same in one hour. Thus, it should have a big impact, as there are also other neurologic diseases and their treatment that can be investigated in 3D.

The researchers are planning to obtain brain scans of both mouse embryos and adult mice. They hope to gain better knowledge about how mammalian brain networks change during development and learning. This could not only give key insights about how mammalian brains evolve over time but also about how information networks are affected or altered in disease states.


Related Links:
Vienna University of Technology

New
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
New
HPV Molecular Test
BD Onclarity HPV Assay
New
Japanese Encephalitis Test
Japanese Encephalitis Virus Real Time PCR Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Plasma pTau217 testing can predict future amyloid accumulation and cognitive decline in cognitively healthy older adults (photo courtesy of Shutterstock)

Blood Test Predicts Alzheimer Disease Risk Before Imaging Changes and Symptoms

Alzheimer's disease often advances silently for years, making timely risk stratification difficult in routine practice. Current approaches to detect pathology can involve lumbar puncture or positron emission... Read more

Industry

view channel
Image: Pathlight combines WGS and dPCR to identify and longitudinally track large‑scale genomic changes, known as structural variants (photo courtesy of SAGA Diagnositcs)

Roche Affiliate Expands MRD Portfolio with SAGA Acquisition

Foundation Medicine, Inc., an independent affiliate of Roche, announced plans to expand its monitoring portfolio with SAGA Diagnostics’ Pathlight, a personalized, tumor-informed molecular residual disease... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.